Theravance Biopharma
TBPH
TBPH
84 hedge funds and large institutions have $1.31B invested in Theravance Biopharma in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $1.62B → $1.31B (-$312M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
100% less call options, than puts
Call options by funds: $2K | Put options by funds: $944K
Holders
84
Holding in Top 10
2
Calls
$2K
Puts
$944K
Top Buyers
| 1 | +$2.94M | |
| 2 | +$1.81M | |
| 3 | +$1.37M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.36M |
| 5 |
WIM
Woodford Investment Management
London,
United Kingdom
|
+$1.14M |
Top Sellers
| 1 | -$6.16M | |
| 2 | -$4.43M | |
| 3 | -$2.56M | |
| 4 |
BlackRock
New York
|
-$1.71M |
| 5 |
Goldman Sachs
New York
|
-$1.65M |